Media

ConvaTec Group Plc First Half Results 2019

 

01 August 2019

Download Full Press Release

 

Improving growth trend in second quarter, Transformation Initiative on track, guidance confirmed.

Key points:

  • Group reported revenue of $888.9 million in the first half was 3.5% lower year on year and flat1 on an organic basis;
    • Excluding the one-off rebate provision6 taken in the first quarter ($8.9 million) to revise the estimate of the distributor rebates accrual, growth in the first half was 1.0%1 on an organic basis;
    • The second quarter saw an improving revenue trend, with positive organic revenue growth across all franchises and Group growth of 2.1%1;
  • Transformation Initiative on track: three-year programme, $150 million investment (including c.$45 million capex), anticipated gross benefits in 2021 of $130 – $150 million per annum;
    • $14 million cost in first half;
    • Operational Excellence programme delivered net positive productivity in the first half, with benefits more than offsetting inflation and depreciation;
  • Reported operating profit / EBIT of $93.6 million, 23.3% lower year on year, reflecting the one-off rebate provision6, foreign exchange, plus investment in commercial areas and regions, and the Transformation Initiative;
  • Adjusted2 operating profit / EBIT of $165.2 million, 18.8% lower year on year, due to same drivers as above; adjusted2 EBIT margin declined, as expected, to 18.6% (2018: 22.1%);
  • Interim dividend 1.717 cents maintained;
  • Leverage 2.6 times Net Debt/EBITDA3, continued good adjusted cash conversion 89.8% (2018: 75.2%);
  • Guidance for the full year maintained: organic revenue growth 1.0% - 2.5%1, adjusted EBIT2 margin 18% - 20%, including c. $40 million Transformation Initiative and c. $10 million of MDR4 costs.

 
Group Revenue


Rick Anderson, Executive Chairman, commented

“All of our Franchises delivered organic1 revenue growth in the second quarter, indicating positive progress against our performance improvement plans. There is more work to do, but we are well positioned to deliver on our objectives for the full year and consequently our revenue and adjusted EBIT margin guidance is maintained. Throughout the second half of the year, our priority remains improving execution. In addition, I look forward to welcoming Karim Bitar as our new CEO on 30 September.

We expect to see further revenue growth for the Group in the second half. A key focus area is our US Wound business, where a more targeted and effective salesforce is already showing encouraging signs. Ostomy is continuing to deliver a slow but steady recovery, and within Continence and Critical Care our Home Distribution Group (HDG) continues to outgrow the market in the US, albeit at a lower rate. Infusion Devices saw strong orders from customers in the second quarter.

Our Transformation Initiative has made good progress in many areas, but there is much more to do. Launched in February, we invested $14 million in the first half to establish the programme, identify opportunities and begin execution of the first wave of projects, with detailed tracking of key milestones and weekly reviews by the Executive team. Our Transformation Office provides a model to embed more discipline and better execution into the business: initial progress is encouraging and a “ConvaTec Way” is emerging.

We expect a significant increase in transformation spend in the second half, in line with previous guidance of $40 million spend for the year, as more projects move from planning into execution. We will continue to “forward invest” for growth and efficiency, to enable us to capture more opportunities for value creation over the medium to long term for all our stakeholders.”

(...)

Download the full text of this announcement and Analyst Presentation 

 

Enquiries

 
Analysts and Investors 
                                                                                                                     

investorrelations@convatec.com

 

 

 

John Crosse, VP Investor Relations

+44 (0)7500 141435

 

 

 

Mark Reynolds, Director Investor Relations

+44 (0)7551 036625

 

 

 


Media


mediarelations@convatec.com

 

 

 

Bobby Leach, VP Group Corporate Affairs                      

+44 (0)7770 842226

 

 

 

Finsbury

+44 (0)207 2513801

 

 

 

 

 

Cookies are needed for this website to work optimally. They also help us to know a little bit about how you use our website, which improves the browsing experience.  Cookies on this site are used for traffic measurement and optimisation of page content only. By continuing to browse on this website, you indicate your consent to the use of cookies.  You may block the use of cookies by following the "How to block and avoid cookies" instructions

Learn more about our Cookie policy